Search Result "vascular endothelialgrowth factor (VEGF)"
Anti-VEGF Treatment in Corneal Diseases
Journal: Current Drug Targets
Volume: 21 Issue: 12 Year: 2020 Page: 1159-1180
Author(s): Giuseppe Giannaccare,Marco Pellegrini,Cristina Bovone,Rossella Spena,Carlotta Senni,Vincenzo Scorcia,Massimo Busin
Therapeutic Angiogenesis in Ischemic Heart Disease: Gene or Recombinant Vascular Growth Factor Protein Therapy?
Journal: Current Gene Therapy
Volume: 3 Issue: 3 Year: 2003 Page: 197-206
Author(s): Jens Kastrup
Resistance to Anti-VEGF Agents
Journal: Current Pharmaceutical Design
Volume: 10 Issue: 1 Year: 2004 Page: 51-64
Author(s): Ton N. C., Jayson G. C.
Triamcinolone Acetonide Suppresses Inflammation and Facilitates Vascular Barrier Function in Human Retinal Microvascular Endothelial Cells
Journal: Current Neurovascular Research
Volume: 14 Issue: 3 Year: 2017 Page: 232-241
Author(s): Shunsuke Imai,Tomohiro Otsuka,Akira Naito,Masamitsu Shimazawa,Hideaki Hara
Luteolin Inhibits Smooth Muscle Cell Migration and Proliferation by Attenuating the Production of Nox4, P-Akt and VEGF in Endothelial Cells
Journal: Current Pharmaceutical Biotechnology
Volume: 14 Issue: 12 Year: 2013 Page: 1009-1015
Author(s): Hong Ding,Dongye Li,Yanbin Zhang,Tian Zhang,Hong Zhu,Tongda Xu,Yuanyuan Luo,Cheng Wang
Rational Design of Anti-Angiogenic Peptides to Inhibit VEGF/VEGFR2 Interactionsfor Cancer Therapeutics
Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 22 Issue: 10 Year: 2022 Page: 2026-2035
Author(s): Samaneh Ghasemali,Safar Farajnia,Abolfazl Barzegar,Babak Negahdari,Leila Rahbarnia
Post-stroke Constraint-induced Movement Therapy Increases Functional Recovery, Angiogenesis, and Neurogenesis with Enhanced Expression of HIF-1α and VEGF
Journal: Current Neurovascular Research
Volume: 14 Issue: 4 Year: 2017 Page: 368-377
Author(s): Ce Li,Bei Zhang,Yulian Zhu,Yingying Li,Peile Liu,Beiyao Gao,Shan Tian,Liang Du,Yulong Bai
Subclinical Hypothyroidism in Patients with Diabetic Retinopathy: Role ofVascular Endothelial Growth Factor
Journal: Endocrine, Metabolic & Immune Disorders - Drug Targets
Volume: 22 Issue: 5 Year: 2022 Page: 502-509
Author(s): Mervat M. El-Eshmawy,Nehal T. Mohammed,Eman Elsayed,Heba A. Elshahawy,Enas M. Elkhamisy,Amr A. El-Sehrawy
Aflibercept: A Novel VEGF Targeted Agent to Explore the Future Perspectives of Anti-Angiogenic Therapy for the Treatment of Multiple Tumors
Journal: Mini-Reviews in Medicinal Chemistry
Volume: 13 Issue: 4 Year: 2013 Page: 530-540
Author(s): Tina Sharma, Richa Dhingra, Sukhminder Singh, Shivani Sharma, Prince Tomar, Manav Malhotra, T. R. Bhardwaj
Angiogenesis and Hypertension: The Dual Role of Anti-Hypertensive and Anti-Angiogenic Therapies
Journal: Current Vascular Pharmacology
Volume: 10 Issue: 4 Year: 2012 Page: 479-493
Author(s): Patrizia Ferroni,David Della-Morte,Raffaele Palmirotta,Tatjana Rundek,Fiorella Guadagni,Mario Roselli